Market Closed -
Bombay S.E.
06:00:57 2024-06-28 EDT
|
5-day change
|
1st Jan Change
|
49.42
INR
|
-0.14%
|
|
+2.70%
|
+4.99%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
246.8
|
162.3
|
156.5
|
136
|
164.9
|
247.5
|
Enterprise Value (EV)
1 |
496.9
|
375.7
|
409.5
|
390.2
|
419.1
|
260.7
|
P/E ratio
|
-33
x
|
-17.1
x
|
51.4
x
|
115
x
|
-5
x
|
-5.54
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
40,975,491
x
|
17,008,102
x
|
3,199,092
x
|
4,637,873
x
|
3,368,688
x
|
EV / Revenue
|
-
|
94,844,211
x
|
44,501,419
x
|
9,182,292
x
|
11,791,031
x
|
3,548,094
x
|
EV / EBITDA
|
-143
x
|
-43.5
x
|
149
x
|
-298
x
|
-10.1
x
|
-7.03
x
|
EV / FCF
|
-18.2
x
|
9.32
x
|
-10.5
x
|
384
x
|
-14.5
x
|
-1.15
x
|
FCF Yield
|
-5.49%
|
10.7%
|
-9.56%
|
0.26%
|
-6.9%
|
-86.7%
|
Price to Book
|
0.73
x
|
0.5
x
|
0.48
x
|
0.42
x
|
0.56
x
|
0.81
x
|
Nbr of stocks (in thousands)
|
3,399
|
3,399
|
3,399
|
3,399
|
3,399
|
7,478
|
Reference price
2 |
72.60
|
47.75
|
46.05
|
40.00
|
48.50
|
33.10
|
Announcement Date
|
8/14/18
|
9/4/19
|
11/28/20
|
9/3/21
|
9/6/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
3.961
|
9.203
|
42.5
|
35.54
|
73.48
|
EBITDA
1 |
-3.487
|
-8.641
|
2.749
|
-1.311
|
-41.46
|
-37.07
|
EBIT
1 |
-3.495
|
-8.681
|
2.693
|
-1.62
|
-41.84
|
-40.49
|
Operating Margin
|
-
|
-219.16%
|
29.26%
|
-3.81%
|
-117.71%
|
-55.11%
|
Earnings before Tax (EBT)
1 |
-7.487
|
-9.48
|
3.048
|
2.643
|
-33.03
|
-42.95
|
Net income
1 |
-7.487
|
-9.48
|
3.048
|
1.184
|
-33.01
|
-40.04
|
Net margin
|
-
|
-239.33%
|
33.12%
|
2.79%
|
-92.87%
|
-54.5%
|
EPS
2 |
-2.203
|
-2.789
|
0.8954
|
0.3483
|
-9.700
|
-5.970
|
Free Cash Flow
1 |
-27.27
|
40.31
|
-39.17
|
1.017
|
-28.93
|
-226.1
|
FCF margin
|
-
|
1,017.67%
|
-425.63%
|
2.39%
|
-81.4%
|
-307.69%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
85.91%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/14/18
|
9/4/19
|
11/28/20
|
9/3/21
|
9/6/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
250
|
213
|
253
|
254
|
254
|
13.2
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-71.74
x
|
-24.69
x
|
92.04
x
|
-194
x
|
-6.132
x
|
-0.3556
x
|
Free Cash Flow
1 |
-27.3
|
40.3
|
-39.2
|
1.02
|
-28.9
|
-226
|
ROE (net income / shareholders' equity)
|
-22%
|
-2.87%
|
0.94%
|
0.36%
|
-10.7%
|
-15.8%
|
ROA (Net income/ Total Assets)
|
-0.62%
|
-0.81%
|
0.25%
|
-0.15%
|
-3.91%
|
-3.89%
|
Assets
1 |
1,216
|
1,171
|
1,219
|
-778.9
|
844.9
|
1,030
|
Book Value Per Share
2 |
99.20
|
95.40
|
95.50
|
95.90
|
86.20
|
41.10
|
Cash Flow per Share
2 |
0.1100
|
10.90
|
0.0500
|
0.2200
|
0.8200
|
0.1600
|
Capex
1 |
0.16
|
0.06
|
-
|
8.46
|
1.53
|
21.9
|
Capex / Sales
|
-
|
1.6%
|
-
|
19.9%
|
4.3%
|
29.87%
|
Announcement Date
|
8/14/18
|
9/4/19
|
11/28/20
|
9/3/21
|
9/6/22
|
9/5/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.99% | 4.43M | | +0.73% | 99.64B | | -11.38% | 58.77B | | +75.71% | 48.81B | | +5.26% | 34.94B | | +0.61% | 31.15B | | +3.47% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -6.67% | 12.73B |
Other Commodity Chemicals
|